Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-10

Clinical Trial Update: Efficacy and Safety of Rapamycin to Complex Vascular Anomalies in Pediatric Patients [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update examining the efficacy and safety of rapamycin for pediatric vascular anomalies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rapamycin (sirolimus)

Snippet

Sponsor: Zhujiang Hospital | Conditions: Vascular Anomalies | Phase 2, Phase 3 | Status: UNKNOWN